Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2011 4
2012 3
2013 3
2014 4
2015 2
2016 1
2017 1
2018 1
2019 1
2020 3
2021 3
2022 1
2023 2
2024 4
2025 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Global, multi-center, repeat-dose, phase 2 study of RZ358 (ersodetug), an insulin receptor antibody, for congenital hyperinsulinism.
Demirbilek H, Melikyan M, Iotova V, Galcheva S, Ozbek MN, Dastamani A, Kheladze N, Mazor-Aronovitch K, Clemente M, Empting S, Mohnike K, Christesen HT, Thornton PS, De Leon DD, Hood D, O'Boyle E, Roberts BK. Demirbilek H, et al. Among authors: mazor aronovitch k. Med. 2025 Jun 13;6(6):100611. doi: 10.1016/j.medj.2025.100611. Epub 2025 Mar 18. Med. 2025. PMID: 40107271 Free article. Clinical Trial.
Youth-onset type 2 diabetes in Israel: A national cohort.
Zuckerman Levin N, Cohen M, Phillip M, Tenenbaum A, Koren I, Tenenbaum-Rakover Y, Admoni O, Hershkovitz E, Haim A, Mazor Aronovitch K, Zangen D, Strich D, Brener A, Yeshayahu Y, Schon Y, Rachmiel M, Ben-Ari T, Levy-Khademi F, Tibi R, Weiss R, Lebenthal Y, Pinhas-Hamiel O, Shehadeh N. Zuckerman Levin N, et al. Among authors: mazor aronovitch k. Pediatr Diabetes. 2022 Sep;23(6):649-659. doi: 10.1111/pedi.13351. Epub 2022 Jun 1. Pediatr Diabetes. 2022. PMID: 35521999
Real-Life Achievements of MiniMed 780G Advanced Closed-Loop System in Youth with Type 1 Diabetes: AWeSoMe Study Group Multicenter Prospective Trial.
Gruber N, Wittenberg A, Brener A, Abiri S, Mazor-Aronovitch K, Yackobovitch-Gavan M, Averbuch S, Ben Ari T, Levek N, Levran N, Landau Z, Rachmiel M, Pinhas-Hamiel O, Lebenthal Y. Gruber N, et al. Among authors: mazor aronovitch k. Diabetes Technol Ther. 2024 Nov;26(11):869-880. doi: 10.1089/dia.2024.0148. Epub 2024 May 31. Diabetes Technol Ther. 2024. PMID: 38758194
A comparison of the usage of an open-source automated insulin delivery system and the MiniMed™ 780 G system in children and adolescents with type 1 diabetes in real-world settings: the AWeSoMe study group.
Landau Z, Lebenthal Y, Mazor-Aronovitch K, Brener A, Levek N, Jacobi-Polishook T, Ben Ari T, Abiri S, Haim A, Nir J, Rachmiel M, Pinhas-Hamiel O. Landau Z, et al. Among authors: mazor aronovitch k. Endocrine. 2024 Jun;84(3):943-950. doi: 10.1007/s12020-024-03683-w. Epub 2024 Jan 16. Endocrine. 2024. PMID: 38225516
An "out of the box" approach for prevention of ketoacidosis in youth with poorly controlled type 1 diabetes: combined use of insulin pump and long-acting insulin.
Barash G, Lerman L, Ben-Ari T, Abiri S, Landau Z, Ben Ami M, Brener A, Lebenthal Y, Pinhas-Hamiel O, Mazor-Aronovitch K, Haim A, Yeshayahu Y, De Vries L, Rachmiel M. Barash G, et al. Among authors: mazor aronovitch k. Acta Diabetol. 2024 Oct;61(10):1241-1249. doi: 10.1007/s00592-024-02264-7. Epub 2024 May 18. Acta Diabetol. 2024. PMID: 38762619 Free PMC article.
Virtual reality's impact on children with type 1 diabetes: a proof-of-concept randomized cross-over trial on anxiety, pain, adherence, and glycemic control.
Gruber N, Shemesh-Iron M, Kraft E, Mitelberg K, Mauda E, Ben-Ami M, Mazor-Aronovitch K, Levy-Shraga Y, Levran N, Levek N, Zimlichman E, Pinhas-Hamiel O. Gruber N, et al. Among authors: mazor aronovitch k. Acta Diabetol. 2024 Feb;61(2):215-224. doi: 10.1007/s00592-023-02195-9. Epub 2023 Oct 16. Acta Diabetol. 2024. PMID: 37845502 Clinical Trial.
32 results